Clinical Trial: USOR 21400

Trial Status: Open
Disease Types: Solid Tumors All, Gynecologic
Trial ID USOR 21400
Sponsor ID TJ004309STM103

A Phase 2 Clinical Study of TJ004309 in Combination with Atezolizumab in Patients with Advanced or Mets Ovarian Cancer and Selected Advanced Solid Tumors.


Fairfax Office

Gainesville Office

Loudoun Office

Alexandria Office

Learn More About This Trial

Other Relevant Trials
Trial ID 516-014
Sponsor ID Mirati

A Multicenter, Open-Label, Extension Study of the Safety and Tolerability of Sitravatinib Alone or in Combination with Other Anticancer Therapies in Patients with Advanced or Metastatic Solid Malignancies

Trial ID JBI-802-101
Sponsor ID Jubilant Therapeutics

A First-in-Human, Open-Label, Dose Escalation and Expansion Study of Orally Administered JBI-802 in Patients with Advanced Solid Tumors